北京时间11月11日消息,大麻制药公司Tilray Brands Inc.(纳斯达克:TLRY)今日股价盘中大跌5.37%,至1.41美元,引起市场广泛关注。
Tilray是一家总部位于加拿大的大麻种植销售公司,主要从事医用及娱乐用途大麻销售业务,面向加拿大本土及国际市场,并涉足美国CBD产品和酒类等相关领域。最新2023财年业绩显示,Tilray全年营收2亿美元,净亏损3917万美元,每股亏损0.04美元,市盈率为-5.28倍。
分析人士指出,Tilray业绩疲软及大麻行业增长放缓是导致其股价大跌的主要因素。与此同时,投资者对Tilray未来发展前景依然持谨慎观望态度,这也是引发股价重挫的潜在原因。此外,券商评级显示大部分机构给予Tilray"持有"评级,仅21%机构建议"买入",机构观望情绪或加剧股价波动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.